Dataset Information


Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion.

ABSTRACT: Apolipoprotein A-IV (apoA-IV) is secreted by the small intestine in response to fat absorption. Here we demonstrate a potential role for apoA-IV in regulating glucose homeostasis. ApoA-IV-treated isolated pancreatic islets had enhanced insulin secretion under conditions of high glucose but not of low glucose, suggesting a direct effect of apoA-IV to enhance glucose-stimulated insulin release. This enhancement involves cAMP at a level distal to Ca(2+) influx into the ? cells. Knockout of apoA-IV results in compromised insulin secretion and impaired glucose tolerance compared with WT mice. Challenging apoA-IV(-/-) mice with a high-fat diet led to fasting hyperglycemia and more severe glucose intolerance associated with defective insulin secretion than occurred in WT mice. Administration of exogenous apoA-IV to apoA-IV(-/-) mice improved glucose tolerance by enhancing insulin secretion in mice fed either chow or a high-fat diet. Finally, we demonstrate that exogenous apoA-IV injection decreases blood glucose levels and stimulates a transient increase in insulin secretion in KKAy diabetic mice. These results suggest that apoA-IV may provide a therapeutic target for the regulation of glucose-stimulated insulin secretion and treatment of diabetes.


PROVIDER: S-EPMC3386109 | BioStudies | 2012-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4882499 | BioStudies
2019-01-01 | S-EPMC6487711 | BioStudies
2020-01-01 | S-EPMC7082546 | BioStudies
2018-01-01 | S-EPMC6071761 | BioStudies
1000-01-01 | S-EPMC2518494 | BioStudies
2013-01-01 | S-EPMC3965668 | BioStudies
2019-01-01 | S-EPMC6777806 | BioStudies
1000-01-01 | S-EPMC2812035 | BioStudies
2013-01-01 | S-EPMC3614946 | BioStudies
2018-01-01 | S-EPMC5826869 | BioStudies